Patent details

EP1576138 Title: 2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION

Basic Information

Publication number:
EP1576138
PCT Application Number:
PCT/US/2003/036714
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP037964129
PCT Publication Number:
WO/2004/046331
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2'-METHYL NUCLEOSIDES IN COMBINATION WITH INTERFERON AND FLAVIVIRIDAE MUTATION
French Title of Invention:
2'-MÉTHYL-NUCLEOSIDES EN COMBInaISON AVEC l'INTERFÉRON ET MUTATION DE FLAVIVIRIDAE
German Title of Invention:
2'-METHYL NUKLEOSIDE IN KOMBINATION MIT INTERFERON UND FLAVIVIRIDAE-MUTATION
SPC Number:

Dates

Filing date:
17/11/2003
Grant date:
01/02/2017
EP Publication Date:
01/02/2017
PCT Publication Date:
03/06/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/09/2005
EP B1 Publication Date:
01/02/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/11/2023
Renunciation date:
Revocation date:
21/03/2019
Annulment date:

Owner

From:
26/05/2017
 
 

Name:
Idenix Pharmaceuticals LLC
Address:
320 Bent Street, Cambridge, MA 02141, United States (US)

Name:
Università Degli Studi di Cagliari
Address:
Via Università n. 40, 09124 Cagliari, Italy (IT)

History of Owners

From:
03/02/2017
To:
26/05/2017

Name:
Idenix Pharmaceuticals LLC
Address:
320 Bent Street, Floor 4, Cambridge, MA 02141, United States (US)

Name:
Università Degli Studi di Cagliari
Address:
Via Università n. 40, 09124 Cagliari, Italy (IT)

From:
17/11/2003
To:
03/02/2017

Name:
Idenix Pharmaceuticals LLC
Address:
320 Bent Street, Floor 4, Cambridge, MA 02141, United States (US)

Name:
Università Degli Studi di Cagliari
Address:
Sez. Microbiologia, Dip. Biologia Sperimentale KM 4. 500 St, 09042 Monserrato, (CA), Italy (IT)

Agent

Name:
VALIPAT
From:
14/04/2017
Address:
Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
To:

Inventor

1

Name:
LA COLLA Paolo
Address:
Italy (IT)

2

Name:
QU Lin
Address:
United States (US)

3

Name:
SOMMADOSSI Jean-Pierre
Address:
United States (US)

4

Name:
BICHKO Vadim
Address:
United States (US)

5

Name:
STANDRING David
Address:
United States (US)

Priority

Priority Number:
426675 P
Priority Date:
15/11/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/7052;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2019/09
Publication date:
05/08/2019
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201710
Publication date:
08/03/2017
Description:
Transfer of Rights

2

Issue number:
201726
Publication date:
28/06/2017
Description:
Transfer of Rights

3

Issue number:
201749
Publication date:
06/12/2017
Description:
Opposition procedure started

4

Issue number:
201931
Publication date:
31/07/2019
Description:
Revocation of the European patent

Deed

Power of attorney

Change Kind/ Decision Type:
Assignment
Deed Number:
RC20170000097A
Date Registered:
14/04/2017
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
VALIPAT
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
05/11/2018
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
14/04/2017 Request For Change 2